1.Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction.

Wenyu FU ; Yujianan CHEN ; Kaidi WANG ; Aubryanna HETTINGHOUSE ; Wenhuo HU ; Jing-Quan WANG ; Zi-Ning LEI ; Zhe-Sheng CHEN ; Kenneth A STAPLEFORD ; Chuan-Ju LIU

Protein & Cell 2021;12(7):586-591